Phibro Animal Health (PAHC) → Stock, financial statements

Phibro Animal Health: stocks, financial statements

Dividends News

Manufactures and markets animal health pharmaceutical and nutritional products

  • PAHC Ticker
  • 🇺🇸 NASDAQ Exchange
  • 1,500 Employees
2 rated

Financial statements — Phibro Animal Health

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 ← 16 2020 2019 2018 2017 2016
Total Revenue
800M 830M 820M 760M 750M
Cost Of Revenue
540M 560M 550M 520M 510M
Gross Profit
260M 260M 270M 250M 240M
Research and Development
0 0 0 0 0
Selling General and Admin
190M 180M 170M 150M 150M
Operating Expense
730M 740M 720M 670M 670M
Operating Income
69M 83M 99M 98M 86M
Other Income Expense Net
0 0 0 0 0
69M 83M 99M 98M 86M
Interest Income
13M 12M 12M 15M 17M
Pretax Income
56M 72M 88M 81M 77M
Income Tax
22M 17M 23M 16M -6M
Minority Interest
0 0 0 0 0
Net Income
34M 55M 65M 65M 83M
Net Income Basic
34M 55M 65M 65M 83M
20 ← 16 2020 2019 2018 2017 2016
Current cash
91M 82M 79M 56M 34M
Short term investments
37M 27M 22M 21M 18M
130M 160M 140M 130M 120M
200M 200M 180M 160M 170M
Other current assets
37M 27M 22M 21M 18M
Current assets
450M 470M 420M 360M 340M
Long term investments
330M 260M 260M 260M 270M
Property plant equipment
150M 140M 130M 130M 130M
53M 27M 27M 24M 21M
Intangible assets
71M 47M 52M 55M 60M
Other assets
16M 19M 22M 21M 22M
Total assets
780M 730M 670M 620M 610M
Accounts payable
66M 73M 59M 57M 60M
Current long term debt
19M 13M 13M 6.3M 2.8M
Other current liabilities
72M 68M 71M 53M 46M
Total current liabilities
160M 150M 140M 120M 110M
Long term debt
370M 310M 300M 310M 350M
Other liabilities
53M 43M 44M 50M 61M
Minority Interest
0 0 0 0 0
Total Liabilities
600M 510M 490M 470M 520M
Common stock
40M 40M 40M 40M 39M
Retained earning
180M 170M 130M 83M 34M
Treasury stock
0 0 0 0 0
Capital surplus
Shareholder equity
190M 220M 180M 150M 90M
Net tangible assets
65M 140M 110M 73M 9.3M
20 ← 16 2020 2019 2018 2017 2016
Net Income
34M 55M 65M 65M 83M
32M 28M 27M 26M 23M
Changes in receivables
-33M 23M 9.9M 2.1M 13M
Changes in inventories
-1.7M 20M 17M -6.5M 18M
Cash change
9.8M 2.4M 23M 22M 4.4M
Cash flow
59M 47M 70M 98M 37M
Capital expenditures
-34M -30M -19M -21M -36M
Investing activity other
Total investing cash flows
-120M -14M -85M -22M -83M
Dividends paid
Net borrowings
260M 220M 210M 240M 300M
Other financing cash flows
Cash flow financing
41M -4.1M -12M -54M 50M
Exchange rate effect